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Mutations in the gene for guanylate cyclase-activating protein-1 (GCAP1) (GUCA1A) have been associated with 
autosomal dominant cone dystrophy (COD3). In the present study, a severe disease phenotype in a large white 
family was initially shown to map to chromosome 6p21.1, the location of GUCA1A. Subsequent single-stranded 
conformation polymorphism analysis and direct sequencing revealed an A464G transition, causing an E155G 
substitution within the EF4 domain of GCAP1. Modeling of the protein structure shows that the mutation eliminates 
a bidentate amino acid side chain essential for Ca2+ binding. This represents the first disease-associated mutation 
in GCAP1, or any neuron-specific calcium-binding protein within an EF-hand domain, that directly coordinates 
Ca2+. The functional consequences of this substitution were investigated in an in vitro assay of retinal guanylate 
cyclase activation. The mutant protein activates the cyclase at low Ca2+ concentrations but fails to inactivate at 
high Ca2+ concentrations. The overall effect of this would be the constitutive activation of guanylate cyclase in 
photoreceptors, even at the high Ca2+ concentrations of the dark-adapted state, which may explain the dominant 
disease phenotype.
Introduction
Autosomal dominant cone dystrophies are a type of he­
reditary macular degeneration characterized by a pro­
gressive dysfunction of the photopic system, with pres­
ervation of scotopic function. They occur in the 
population with a frequency of —1/10,000 (Small et al. 
1996). The disease presents as the phenotypic triad of 
loss of color vision, photophobia, and reduced central 
visual acuity and is distinguished from the cone-rod dys­
trophies, in which some loss of peripheral vision also 
occurs. Cone dystrophy is a genetically heterogeneous 
disorder, with phenotype linked to loci on 17pl2-13 
(Balciuniene et al. 1995; Small et al. 1996), Xp21.1- 
p l l .3  (Jacobsen et al. 1989), 6q25-q26 (retinal cone 
dystrophy 1 [MIM 180020]), and 6p21.1 (Payne et al.
1998). In the case of 6p21.1, mutations have been iden-
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tified in G U C A 1 A  (COD3 [MIM 602093 and 600364]) 
(Payne et al. 1998; Downes et al. 2001), the gene that 
encodes guanylate cyclase-activating protein-1 (GCAP1).
GCAP1 is a key component in the recovery of photo­
receptor cells to the dark-adapted state after exposure 
to a light stimulus. This recovery process is mediated 
via a change in intracellular free calcium ions in re­
sponse to  a decrease in the level of cyclic guanosine 
m onophosphate (cGMP); both calcium ions and cGMP 
are fundamental secondary messengers in photorecep­
tors. Several mechanisms, highly conserved across spe­
cies, have developed to maintain a low |C a’ | ...... within
photoreceptors. In the dark-adapted state, the |C a’ 
in photoreceptor outer segments rises to ~500 nM  be­
cause of the influx of Ca2+ through open cGMP-gated 
Na /C a’ channels (Dizhoor and Hurley 1999). Ex­
posure to  light leads to the hydrolysis of cGMP by phos­
phodiesterase (via a rhodopsin-mediated cascade) and 
to a subsequent decrease in |C a’ to  ~30 nM  because 
of the continued efflux of Ca2+ through light-indepen­
dent Na /K /C a’ exchangers (Baylor 1996; Koutalos 
and Yau 1996; Pugh et al. 1996; Sampath et al. 1998). 
This decrease in |C a ’ | ...... stimulates an increase in
cGMP, synthesized by two distinct retina-specific iso­
forms of guanylate cyclase (RetGCl and RetGC2), in
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a feedback mechanism vital to the process of light ad­
aptation and the recovery of the dark-adapted state 
(Hayashi and Yamazaki 1991; Shyjan et al. 1992; Di- 
zhoor et al. 1994; Garbers and Lowe 1994; Goraczniak 
et al. 1994; Lowe et al. 1995; Sitaramayya et al. 1995; 
Yang et al. 1995; Pugh et al. 1997).
The RetGCs are not directly sensitive to changes in 
[Ca2*]h.ee; calcium exerts its regulatory effect via spe­
cialized calcium-binding proteins known as guanylate 
cyclase-activating proteins (GCAPs) (Dizhoor et al. 
1994; Palcewski et al. 1994; Dizhoor et al. 1995; Gor- 
czyza et al. 1995; Lowe et al. 1995; Haeseleer et al.
1999). Three mammalian isoforms have been identified, 
GCAP1 (Palczewski et al. 1994), GCAP2 (Dizhoor et 
al. 1995; Gorczyca et al. 1995) and GCAP3 (Haeseleer 
et al. 1999). GCAPs belong to a subgroup of the neuron- 
specific calcium-binding proteins (NCBPs), which in­
cludes recoverin. All NCBPs incorporate four variably 
functional repeats of the EF-hand domain (Polans et al. 
1996), a helix-loop-helix structural domain with a se­
lectively high affinity for Ca ’ ' binding (kD <10~5 M) 
(Nockolds et al. 1972). In the case of the GCAPs, only 
EF2, EF3, and EF4 are functional. Numerous studies 
have demonstrated that the GCAPs function to mediate 
the calcium-sensitive synthesis of cGMP by RetGC 
(Koch and Stryer 1988; Pittler and Baehr 1991; Dizhoor 
et al. 1994, 1995; Palczewski et al. 1994; Goryczya et 
al. 1995; Lowe et al. 1995; Duda et al. 1996; Frins et 
al. 1996; Pugh et al. 1997; Rudnicka-Nawrot et al. 
1998; Haeseleer et al. 1999), activating the cyclase at 
[Ca2*]ftee<100 nM  and inhibiting the cyclase at [Ca2*]ftee 
>500 nM , concentrations characteristic of light- and 
dark-adapted photoreceptors, respectively. This distin­
guishes the GCAPs from other calcium-binding pro­
teins, which typically activate effector proteins in their 
calcium-loaded forms.
The genes for human GCAP1 and GCAP2 reside in 
a tail-to-tail array on chromosome 6p21.1 (Subbaraya 
et al. 1994; Surguchov et al. 1997; Howes et al. 1998) 
and share a common four-exon/three-intron arrange­
ment. GCAP3 shares the same exon/intron arrangement 
but has been localized to chromosome 3ql3 .1  (Hae­
seleer et al. 1999). This suggests that the three GCAP 
genes arose as a result of the duplication and translo­
cation of a common ancestral gene. All three proteins 
have been localized to the retina in various species, with 
GCAP1 present in higher concentrations in cone than 
in rod outer segments (Gorczyca et al. 1995; Cuenca et 
al. 1998). GCAP2 is localized to rods (Dizhoor et al. 
1995), cone inner segments (Otto-Bruc et al. 1997), and 
layers of the inner retina (Cuenca et al. 1998; Howes 
et al. 1998).
To date, two m utations have been identified in 
GCAP1. A Y99C substitution causes a severe cone dys­
trophy (Payne et al. 1998), and a P50L substitution is
associated with a more variable phenotype, ranging 
from mild cone dystrophy to pronounced cone-rod dys­
trophy (Downes et al. 2001). In the present article, we 
report the clinical and genetic characteristics of a family 
with a severe form of autosomal dominant cone dys­
trophy that segregates a novel E155G m utation in 
GCAP1 (G U C A 1 A ). We also describe the functional 
consequences of this m utation and the ability of the 
m utant protein to regulate RetGC activity in response 
to calcium ion changes. This represents the first disease- 
causing m utation found in the highly conserved 12-res­
idue Ca2*-binding m otif of an EF hand.
Material and Methods
Subjects
Approval from the Institutional Review Board of the 
Cleveland Clinic Foundation was obtained for the pre­
sent study, and informed consent was obtained from all 
patients. Of 67 individuals at risk for a dominantly in­
herited cone dystrophy in a large white kindred, 33 were 
found to be affected.
Clinical and Functional Investigations
A visual history was obtained from all patients, and 
best corrected visual acuities were assessed. Ophthal­
moscopic examination was performed on all patients, 
and fluorescein angiography and electroretinography 
were performed on one patient. Blood samples were ob­
tained by venipuncture.
After initial dark adaptation, electroretinograms 
(ERGs) were made, using a bipolar Burian-Allen contact 
lens electrode, to record response to stimuli presented 
within an LKC ganzfeld. The response was differentially 
amplified (band-pass: 0.3-500 Hz), averaged, and stored 
using an LKC UTAS E-2000 signal-averaging system. 
Responses were initially recorded from the dark-adapted 
eyes, using a low-intensity (—24-dB attenuation) and 
high-intensity (0-dB attenuation) strobe flash. A steady 
adapting field was then used to desensitize the rod re­
sponse. After a 7-min period of light adaptation (Peachey 
et al. 1989), high-intensity responses were superimposed 
on the adapting field.
Genetic Linkage and Mutation Screening
DNA was extracted from blood samples, and genetic 
linkage was assessed using microsatellite marker 
D6S1017, which is linked to the GCAP1 locus. Linkage 
analysis was performed under the assumption that the 
disease-allele frequency is .0001 and that the mode of 
inheritance is autosomal dominant, with a penetrance 
of 90% . Each of the four exons of the GCAP1 gene was 
amplified by PCR and analyzed by SSCP, using the 
method of Orita et al. (1989). M utational screening was
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Figure 1 Autosomal dominant inheritance of cone dystrophy. Individuals are identified by generation and pedigree number; squares 
indicate males, and circles indicate females. Blackened symbols indicate affected individuals; open symbols, indicate unaffected individuals.
then performed by direct sequencing of PCR-amplified 
DNA fragments corresponding to each exon of the gene. 
Each fragment was sequenced on both strands. Sequenc­
ing was performed with the Taq DyeDeoxy Terminator 
Cycle Sequencing Kit (Applied Biosystems), according to 
the manufacturer’s instructions.
Mutagenesis o f GCAP1 and Expression in Escherichia 
col i
An E155G point m utation was introduced into human 
wild-type GCAP1, using a GeneEditor site-directed mu­
tagenesis kit (Promega) and the following mutagenesis 
primer: 5'-CT TCC CTG GAA GGG 111 ATA GAG 
G-3'. The wild-type GCAP1 clone used for the m uta­
genesis carried an artificial E6S substitution to facilitate 
N-myristoylation of the protein, which has been found 
to be necessary for the activation of RetG Cl by GCAP1 
(Frins et al. 1996). The mutated sequence was cloned in 
pET3a (Novagen) and expressed in E . coli strain
BL21(DE3)pBBLysS (Newbold et al. 2001). This strain 
carries the pBBLysS plasmid-encoding yeast N-myris- 
toyltransferase, which is coexpressed with the GCAP1 
and effects N-terminal modification of the latter protein. 
Conditions for the expression and subsequent purifica­
tion of the wild-type and E155G proteins were as de­
scribed by Newbold et al. (2001).
Assay of R e tG C l Activation
Hum an RetG Cl was produced in HEK 293T cells 
transiently transfected with a pRC.CMV RetG Cl con­
struct (provided by J. B. Hurley) and isolated in the form 
of a membrane preparation, as described by Wilkie et 
al. (2000). Measurement of guanylate cyclase activity 
was conducted in a radioassay with the use of a f32P]GTP, 
according to the method of Dizhoor et al. (1995), which 
was modified as described by Wilkie et al. (2000). Basal 
activity and activity stimulated by wild-type and mutant 
GCAP1 were measured in reaction buffers containing a
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F igu re  2  Clinical evaluation. A, Fundus photograph from a patient (IV:37) with cone dystrophy, aged 26 years, with visual acuity7 20/ 
200, showing central macular pigmentary changes. B, ERGs recorded from the left (OS) and right (OD) eye of patient V:6 (aged 43 years), 
showing responses to ganzfeld stimuli (times of flash indicated by vertical bars) presented to the dark-adapted eye with a low-intensity strobe 
flash (top row) and with a high-intensity strobe flash (middle row) and to the light-adapted eye with a high-intensity strobe flash (bottom  row). 
Two successive responses are shown for each stimulus condition. Note that the ERG of the light-adapted eye (cone) is diminished below the 
normal range, whereas responses of the dark-adapted eye (rod-dominated) fall within normal limits.
range of [Ca2“]frcc, formulated according to the method 
of Tsien and Pozzan (1989).
R esu lts
Clinical Findings
Clinical evaluations of a large kindred of five gener­
ations revealed an autosomal dominant pattern of in­
heritance (fig. 1). On the basis of the presence of de­
creased visual acuity, abnormalities of color vision, and 
macular lesions, 33 of 67 individuals at risk for inher­
iting the disease were found to be affected. The age at 
onset of decreased visual acuity, color vision defects, and 
photophobia is 8-24 years, with a mean of 16 years. 
Visual loss progresses, during the next two decades, until 
visual acuity is between 20/200 and 20/400. Fundus ex­
amination revealed a central macular lesion with pig­
mentary changes (fig. 2A)
Figure 2B presents ERGs recorded, from the two eyes 
of an affected patient (V:6), under standard stimulation 
and recording conditions. In each stimulation condition,
two successive responses are overlain to demonstrate re­
producibility. The top row shows the rod-mediated 
ERGs obtained from a dim flash presented to the dark- 
adapted eye. The amplitude of the /3-wave falls within 
the range of normal. The middle row shows the response 
of the dark-adapted eye to a high-intensity stimulus 
flash. The negative-polarity a-wave also falls within the 
normal range, and the positive /3-wave was at or slightly 
below the normal range. The bottom row shows the 
response obtained under light-adapted conditions to iso­
late the cone response. For both eyes, the amplitude of 
the cone ERG falls well below the lower limit of the 
normal range.
Genetic Analysis
An initial genotype analysis with marker D6S1017 
yielded a significant LOD score of 3.3 at a recombination 
fraction of 0.1, indicating positive linkage to the GCAP1 
locus. SSCP analysis, followed by direct sequencing, re­
vealed an A-*G transition in nucleotide 464, resulting 
in an E155G amino acid substitution in the EF4 domain
E F 2  Y V E Q M F E T F  D F N K D G Y I D F M E  Y V A G L S L V L  
E F 3 K L R W Y F K L 0  D V D G N G C I D R H E  L L T I I Q A I R  
E F 4  F T D T V F S K I  D V N G D G E L S L E §  F I E G V Q K D Q
F igu re  3 Alignment of the three functional EF-hand domains in GCAP1. The a-helix and loop regions of the domain are identified above 
the sequences. Residues in the loop that coordinate the Ca2 ion are marked with an asterisk. The invariant Glu residues at position 12 of each 
Ca2 -binding loop (E75, E l l l ,  and E155) are highlighted in bold. The positions of the E155G mutation in EF4 present in our pedigree and of 
the previously reported Y.99C mutation in EF3 are boxed.
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Figure 4 GCAPl titrations of RetGCl activity with wild-type GCAP1 (blackened circles), E155G mutant (blackened triangles) and an 
equimolar mixture of wild-type and E155G mutant (open squares). Curves were fitted to the data points on the basis of the relation v = 
[GCAPl] V„,.„/(K01 w  [GCAPl] + [GCAPl]), where K,„ ’•"’[GCAPl] is the GCAPl concentration required for half maximal activation and where 
Vnllli is the maximum specific activation. Values of Vnllli and Km '•’•’[GCAPl] are derived from the fitted curves are given in table 1.
of GCAPl (fig. 2). This change segregated with the dis­
ease phenotype in the entire family (fig. 1 ), with a m ax­
imum LOD score of 7.0, and it was not found in 200 
normal control subjects. The primary sequences of the 
three functional EF hands in GCAPl identifying the 
E155G m utation present in the pedigree is shown in 
figure 3.
Functional Analysis
An E155G substitution was introduced into wild-type 
human GCAPl by site-directed mutagenesis. This was 
cloned in the vector pET3a and expressed in E. coli cells. 
The GCAPl protein was isolated in a cytosolic extract 
from the cells and purified in a single-column gel-filtra- 
tion procedure, as described by Newbold et al. (2001). 
The purified protein was assayed for its ability to activate 
R etG C l, as described elsewhere (Dizhoor et al. 1995; 
Wilkie et al. 2000). A titration of RetGCl activity 
against increasing concentrations of GCAPl in the pres­
ence of a high substrate (GTP) concentration demon­
strated that the initial rate of cGMP formation reached 
a maximum (saturated) value at high GCAPl concen­
trations, with both wild-type and E155G GCAPl (fig. 
4). The maximum specific activation (Vmax) obtained 
with the mutant GCAPl was slightly lower than that 
obtained with the wild type. However, the GCAPl con­
centration required for half-maximal activation (K m 
w fG CA Pl]) was approximately double that of the wild
type (table 1 ), indicating a lower apparent affinity of 
RetG Cl for m utant than for wild-type GCAPl. An equi­
molar mixture of wild-type and mutant protein, repre­
senting the situation in an individual heterozygous for 
the mutation, yielded intermediate results.
In wild-type GCAPl, binding of Ca2+ ions to the three 
EF hands regulates its ability to activate R etG C l. Thus, 
at [Ca2+]free sslOO nM, RetGCl is activated by GCAPl 
(Dizhoor et al. 1994; Gorczyca et al. 1994), but at mi­
cromolar concentrations it is inhibited (Rudnicka-Na- 
wrot et al. 1998). Ca2+ titrations of RetG Cl activity in 
the presence of wild-type and m utant GCAPl are shown 
in figure 5. With wild-type GCAPl, the [Ca2+]free for half- 
maximal activity was estimated to be ~350 nM. With 
m utant GCAPl, however, the curve shows very little 
inhibition of activity at levels >350 nM. Even at 1 /uM
Table 1
Kinetic Parameters and Km ....[GCAP1] for Activation
of RetGCl by Wild-Type and E155G M utant GCAP1
GCAPl ± SE-’ K,„ ■’•’•’[GCAPl] ± SEb
Wild type 4350 ± 120 0.738 ± 0.106
Wild type/El 55Gc 4219 ± 293 1.103 ± 0.318
E155G 3955 ± 320 1.688 ± 0.453
J Voui. measured as picomoles of cGMP per minute per 
milligram of protein.
b Km measured as micromoles. 
c Equimolar mixture.
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Figure 5 Ca2 sensitivity of activation of wild-type RetGCl by 
wild-type and mutant GCAP1. A , Activation by wild-type (blackened 
circles) and E155G mutant (open circles) GCAP1 and by an equimolar 
mixture of wild-type and E155G mutant (open triangles). B, Activation 
by wild-type (blackened circles) and Y99C mutant (open circles) 
GCAP1. Guanylate cyclase activity was determined in membrane prep­
arations expressing RetGCl activity stimulated with 8 ftM GCAP1 in 
all cases. Results are presented as percentage of maximum RetGCl 
activation (maximum RetGCl activity minus basal activity in absence 
of GCAP1).
(generally regarded as above the maximum physiological 
[Ca2+]free in photoreceptor cells), almost 70% of maxi­
mal activity persists, compared with ~ 10% with the wild 
type. When an equimolar mixture of wild-type and mu­
tant GCAP1 is used, activity at [Ca2+]free levels >350 nM 
is again maintained; at 1 jtM, almost 50% of maximal 
activity persists. Thus, the effect of the m utation is to 
maintain high levels of cyclase activity over the whole
physiologically relevant range of [Ca2+]free. This effect is 
dominant, in that it persists even in the presence of wild­
type GCAP1 protein.
The Y99C m utation in GCAP1 has been shown to 
result in a similar constitutive activation of RetGCl at 
high [Ca2+]free (Dizhoor et al. 1998; Sokal et al. 1998). 
Comparison of the magnitude of the effects of the two 
mutations on RetGC activity (fig. SB) shows that the 
E155G m utation is more severe than Y99C, in that the 
failure to inhibit activity at high [Ca2+]free is more 
pronounced.
Discussion
A novel E155G m utation in G U C A 1 A , the gene encod­
ing GCAP1, has been identified in a family affected by 
autosomal dominant cone dystrophy (COD3). A total 
of three disease-associated mutations, including this one, 
have been reported in G U C A 1 A , the other two involving 
Y99C (Payne et al. 1998) and P50L substitutions 
(Downes et al. 2001). All three disorders may present 
with a clinical diagnosis of cone dystrophy, but they 
differ in severity. E155G is similar to Y99C, in that it 
causes a severe phenotype. However, the mean age at 
onset of disease (16 years) is noticeably earlier in patients 
with E155G than in patients with Y99C, who do not 
have clinical symptoms until at least the third decade of 
life. In contrast, P50L is associated with a generally less- 
severe, but markedly variable, phenotype. This study 
allows us to address the question of how the identity of 
different mutations in the same gene results in variable 
expressivity of the disease.
The E155G m utation occurs w ithin the fourth  EF- 
hand dom ain of GCAP1. EF-hand dom ains comprise 
a helix-loop-helix m otif, the loop region of which 
consists of 12 residues. Several of these residues are 
involved in coordinating the Ca2+ ion via oxygen- 
containing side chains and are frequently glutam ate 
or aspartate. W ithin functional EF-hand domains, an 
invariantglutamate residue is found at position 12 , 
which has been shown to be essential for Ca2+ coordina­
tion (Kretsinger 1976). It is this highly conserved residue 
of EF4 that is m utated in the patients in this family 
affected with dominant cone dystrophy.
X-ray crystallographic models of EF hands in a num ­
ber of calcium-binding proteins have shown that each 
calcium ion coordinates seven oxygen ligands (Stry- 
nadka and James 1989). One of these oxygen ligands 
is provided by a water molecule, and the remaining six 
are provided by oxygen-containing side chains of resi­
dues in the loop. The glutamate at position 12 contrib­
utes both of its side-chain oxygen atoms to  the metal­
ion coordination (i.e., it is bidentate), but the remaining 
four ligands are monodentate. Thus, substitution of 
G lul55 in EF4 by a glycine residue, with no oxygen-
W ilkie  et al.: M utation in G CAP l Causes Cone Dystrophy 477
F igu re  6  Model structure of GCAPl showing the overall fold 
of the molecule. A, Complete structure, showing helices (blue) and 
loops (yellow). The key residues determining the calcium-binding abil­
ity of each F,F hand are shown in space-filling mode and are labeled. 
The EF1 hand, which is predicted to be incapable of binding calcium, 
is shown in orange, to distinguish it from the calcium-binding F,F hands 
2-4 (green). Amino acid residues 50, 99, and 155, which correspond 
to the detected mutations in GCAPl, are shown in pink. The figure 
was produced using SETOR (Evans 1993). Ft, Enlargement of the EF4 
domain, showing the polypeptide backbone in ribbon form (blue) and 
the five amino acid side chains, including E155, that assist in calcium 
coordination (black). The Ca2 ion is shown as a red circle. The figure 
was produced using Swiss-Model (Peitsch 1996).
containing side chain, effectively reduces the number of 
coordinating oxygen ligands from seven to five. As the 
results presented here reveal, this has a drastic effect on 
calcium binding.
A pictorial representation of a model of GCAPl is 
shown in figure 6A . This highlights the positions of the
EF hands and the positions of the E155G m utation and 
the two previously reported mutations, Y99C and P50L. 
The enlargement of the EF4 domain (fig. 6 B ) shows the 
positions of the five amino acid side chains (D144, 
N146, D148, S152, and E155) that assist in calcium 
coordination. Note that there is another glutamate res­
idue in the loop, E150, but this points away from the 
calcium ion and does not appear to contribute to metal 
binding.
The E155G mutation, like the Y99C m utation, results 
in constitutive activation of RetGCl at physiologically 
high [Ca2^]lrei;, although the severity of the effect is some­
w hat greater than that produced by Y99C. Consistent 
with this observation, the onset of disease is earliest in 
patients with the E155G mutation. The E155G m uta­
tion also results in a reduced apparent affinity of the 
protein for R etG C l, an effect not observed with the 
Y99C m utant. Both these effects have been shown to 
persist in the presence of wild-type GCAPl and thus act 
in a dom inant manner. The consequence, in the cell, of 
the reduced apparent affinity for RetG Cl is difficult to 
assess, since the prevailing concentrations of both 
GCAPl and RetGCl are unknown. O n the other hand, 
the constitutive activation of RetGCl would be ex­
pected to result in a persistently elevated level of cGMP 
in the cell, above that required to keep the cGMP-gated 
cation channels open, resulting in maintenance of high 
[Ca2^]lr„. The mechanism of the ensuing photoreceptor 
degeneration is unclear, but it is known that persistently 
elevated calcium levels tend to disrupt the membrane 
potential of the mitochondrial outer membrane, leading 
to release of cytochrome c, w ith subsequent caspase 
activation and apoptosis (Green and Reed 1998). Pre­
vious studies have also linked elevated cGMP levels, 
arising from mutations in the phosphodiesterase gene, 
to cell death (Pittler and Baehr 1991; Farber et al. 1992).
Why mutations in GCAPl result in selective cone de­
generation with preservation of rod function is unclear. 
Cytohistochemical studies have indicated that the con­
centrations of both RetGCl and GCAPl are higher in 
cone photoreceptors than in rod photoreceptors (Liu et 
al. 1994; Kachi et al. 1999). Thus, a m utation in GCAPl 
that affects the cyclase activity might be expected to 
cause a more serious imbalance in cones than in rods. 
However, mutations in the G U C Y 2 D  gene, encoding 
R etG C l, which also result in constitutive RetGCl ac­
tivity, have been linked to cone-rod dystrophy (Kelsell 
et al. 1998; Perrault et al. 1998; Weigell-Weber et al. 
2000; Wilkie et al. 2000). It is therefore difficult to 
explain why severe mutations in GCAPl with similar 
functional consequences do not also affect the rods. One 
difference in the effects of the mutations is that the cone- 
rod mutations in RetG Cl lead to an increased apparent 
affinity for G CAPl, but the E155G m utation in GCAPl 
leads to a decrease in this property. An increased ap­
478 A m . ]. H u m . G enet. 69 :471 -4 8 0 , 2001
parent affinity of the cyclase for GCAP1 will tend to 
exacerbate the failure to abolish cyclase activation at 
high levels of [Ca2*]free, but a reduced apparent affinity 
should compensate for it. In this way, the overall se­
verity of the effect of the E155G m utation may be less­
ened in comparison with the R etG C l mutations, with 
the sparing of the rods.
Rudnicka-Nawrot et al. (1998) have examined the 
effects of inactivation of individual EF hands on the 
function of bovine GCAP1 in vitro. This was accom­
plished through the substitution of glutamate with as­
partate (conserving the negative charge) at position 12 
of the three functional EF motifs in GCAP1, thus al­
tering the affinity of the domains for Ca2* without dis­
rupting their structure. Rudnicka-Nawrot et al. dem­
onstrated that only EF3 and EF4 contribute to the 
Ca2*-dependent inhibition of R etG C l by GCAP1. The 
m utants with a single substitution, E l l  ID  or E155D, 
resulted in ~50%  inhibition of cyclase activity at a 
[Ca2*]free of 500 mM , but double mutants (E l l ID  and 
E155D) and triple mutants (E75D, E l l  ID , and E155D) 
activated cGMP synthesis in a manner completely in­
dependent of [Ca2*]free. In contrast, the results presented 
here demonstrate that the nonconservative substitution 
of the position 12 glutamate by the small neutral residue 
glycine has a more drastic effect on calcium binding, 
with the consequence that a single m utation in EF4 
results in <25%  inhibition of the cyclase activity at a 
calcium concentration of 500 /*M.
Finally, an understanding of the functional effects 
of GCAP1 m utations on signaling w ithin the p h o to ­
receptor is im portant, not only for the elucidation of 
the pathophysiology of these cone dystrophies but 
also, in view of the sequence sim ilarity and conserved 
structural dom ains of all NCBPs, for the study of 
the pathogenesis of retinal dystrophies arising from m u­
tations in other intracellular Ca2*- and cGMP-mediated 
signaling systems.
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